Filing Details

Accession Number:
0001209191-20-041797
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-08 17:46:49
Reporting Period:
2020-07-06
Accepted Time:
2020-07-08 17:46:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1490349 Medley Capital Corp MCC () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1200438 Drawbridge Special Opportunities Fund Lp 1345 Avenue Of The Americas, 46Th Floor
New York NY 10105
No No Yes No
1205824 Ltd Fund Opportunites Special Drawbridge 1345 Avenue Of The Americas, 46Th Floor
New York NY 10105
No No Yes No
1245521 Fig Llc 1345 Avenue Of The Americas, 46Th Floor
New York NY 10105
No No Yes No
1252267 Drawbridge Special Opportunities Advisors Llc 1345 Avenue Of The Americas, 46Th Floor
New York NY 10105
No No Yes No
1380393 Fortress Investment Group Llc 1345 Avenue Of The Americas, 46Th Floor
New York NY 10105
No No Yes No
1380935 Drawbridge Special Opportunities Gp Llc 1345 Avenue Of The Americas, 46Th Floor
New York NY 10105
No No Yes No
1381035 Fortress Principal Investment Holdings Iv Llc 1345 Avenue Of The Americas, 46Th Floor
New York NY 10105
No No Yes No
1387344 Fortress Operating Entity I Lp 1345 Avenue Of The Americas, 46Th Floor
New York NY 10105
No No Yes No
1387345 Fig Corp. 1345 Avenue Of The Americas, 46Th Floor
New York NY 10105
No No Yes No
1792693 Db Med Investor I Llc 1345 Avenue Of The Americas, 46Th Floor
New York NY 10105
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-07-06 3,400 $0.72 6,505,376 No 4 S Indirect See footnote
Common Stock Disposition 2020-07-07 12,713 $0.73 6,492,663 No 4 S Indirect See footnote
Common Stock Disposition 2020-07-08 17,308 $0.70 6,475,355 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Footnotes
  1. The price in Column 4 is a weighted average price. The actual sale prices ranged from $0.71 to $0.74 per share. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  2. Each reporting person disclaims beneficial ownership of all reported shares except to the extent of its pecuniary interest therein and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for the purposes of Section 16 or otherwise. DB Med Investor I LLC, a Delaware limited liability company ("DB Med"), directly owns shares of common stock of the Issuer. Drawbridge Special Opportunities Fund LP, a Delaware limited partnership ("DBSO"), and Drawbridge Special Opportunities Fund LTD, a Cayman Islands exempted company ("DBSO Ltd."), are the members of DB Med. Drawbridge Special Opportunities GP LLC, a Delaware limited liability company ("DBSO GP"), is the general partner of DBSO and DBSO Ltd. Fortress Principal Investment Holdings IV LLC, a Delaware limited liability company ("FPI IV"), is the managing member of DBSO GP. [Footnote continues below]
  3. Drawbridge Special Opportunities Advisors LLC, a Delaware limited liability company ("DBSO Advisors"), is the investment manager of DBSO and DBSO Ltd. FIG LLC, a Delaware limited liability company, is the holder of all of the issued and outstanding interests of DBSO Advisors. Fortress Operating Entity I LP, a Delaware limited partnership ("FOE I"), is the holder of all of the issued and outstanding interests of FPI IV and the Class A member of FIG LLC. FIG Corp., a Delaware corporation, is the general partner of FOE I. Fortress Investment Group LLC, a Delaware limited liability company ("Fortress"), is the holder of all of the issued and outstanding shares of FIG Corp.
  4. The price in Column 4 is a weighted average price. The actual sale prices ranged from $0.72 to $0.73 per share. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  5. The price in Column 4 is a weighted average price. The actual sale prices ranged from $0.70 to $0.72 per share. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.